Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Aldevronaldevron.com · Low evidenceAldevron offers comprehensive manufacturing solutions for gene editing, gene therapy, and RNA vaccines, providing both viral and non-viral vector services from discovery to commercialization. The company also manufactures CRISPR nucleases, plasmids, and mRNA-based therapies, supporting partners in genomic medicine with scalable, high-quality production.
Parse Score
Sources
drugdiscoverynews.com shapes more of what AI says about Aldevron than any other source, at 100% of its citations.